-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
PetVivo (OTCMKTS:PETV) Share Price Passes Above Fifty Day Moving Average of $1.99
PetVivo (OTCMKTS:PETV) Share Price Passes Above Fifty Day Moving Average of $1.99
PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $1.99 and traded as high as $2.35. PetVivo shares last traded at $2.33, with a volume of 19,235 shares traded.
PetVivo Price Performance
The stock has a market cap of $23.22 million, a price-to-earnings ratio of -3.10 and a beta of 1.96. The company has a current ratio of 4.15, a quick ratio of 4.00 and a debt-to-equity ratio of 0.01. The stock has a 50-day moving average price of $1.99 and a two-hundred day moving average price of $1.83.
Get PetVivo alerts:Institutional Investors Weigh In On PetVivo
An institutional investor recently raised its position in PetVivo stock. Vanguard Group Inc. increased its position in shares of PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) by 5.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 226,137 shares of the company's stock after purchasing an additional 11,251 shares during the quarter. Vanguard Group Inc. owned approximately 2.31% of PetVivo worth $461,000 as of its most recent filing with the SEC. 13.70% of the stock is currently owned by hedge funds and other institutional investors.
About PetVivo
(Get Rating)PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
Featured Stories
- Get a free copy of the StockNews.com research report on PetVivo (PETV)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- Skyworks Solutions Is Worth A Look At These Prices
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $1.99 and traded as high as $2.35. PetVivo shares last traded at $2.33, with a volume of 19,235 shares traded.
PetVivo Holdings,Inc.(OTCMKTS:PETV-GET评级)在周一的交易中突破了50日移动均线。该股的50日移动均线为1.99美元,交易价格高达2.35美元。PetVivo的股票最新报2.33美元,成交量为19,235股。
PetVivo Price Performance
PetVivo性价比
The stock has a market cap of $23.22 million, a price-to-earnings ratio of -3.10 and a beta of 1.96. The company has a current ratio of 4.15, a quick ratio of 4.00 and a debt-to-equity ratio of 0.01. The stock has a 50-day moving average price of $1.99 and a two-hundred day moving average price of $1.83.
该股市值为2322万美元,市盈率为-3.10倍,贝塔系数为1.96。该公司的流动比率为4.15,速动比率为4.00,债务权益比率为0.01。该股的50日移动均线价格为1.99美元,200日移动均线价格为1.83美元。
Institutional Investors Weigh In On PetVivo
机构投资者看好PetVivo
An institutional investor recently raised its position in PetVivo stock. Vanguard Group Inc. increased its position in shares of PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) by 5.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 226,137 shares of the company's stock after purchasing an additional 11,251 shares during the quarter. Vanguard Group Inc. owned approximately 2.31% of PetVivo worth $461,000 as of its most recent filing with the SEC. 13.70% of the stock is currently owned by hedge funds and other institutional investors.
一家机构投资者最近提高了对PetVivo股票的头寸。根据先锋集团向美国证券交易委员会披露的最新信息,今年第一季度,先锋集团将PetVivo Holdings,Inc.的股票头寸增加了5.2%。该机构投资者在本季度额外购买了11,251股后,持有226,137股该公司股票。截至最近向美国证券交易委员会提交的文件,先锋集团持有PetVivo约2.31%的股份,价值46.1万美元。13.70%的股票目前由对冲基金和其他机构投资者持有。
About PetVivo
关于PetVivo
PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
PetVivo控股公司是一家生物医疗设备公司,从事治疗动物疾病和疾病的医疗设备和生物材料的制造、商业化和许可。它的主要产品是Spryng,一种由兽医管理的关节内注射,用于治疗跛行和其他关节疾病,如狗和马的骨关节炎。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on PetVivo (PETV)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- Skyworks Solutions Is Worth A Look At These Prices
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
- 免费获取StockNews.com关于PetVivo的研究报告(PETV)
- 3份井喷式收益报告可能标志着转折点
- CrowdStrike是否会延续其盈利排行榜榜首的势头?
- Skyworks Solutions值得看看这些价格
- 3只股票将引领纳斯达克牛市
- MarketBeat播客:ESG--有利可图地投资你的价值
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
接受PetVivo Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对PetVivo和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧